View in EDS HTML Full Text PDF Full Text

The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.

Saved in:
Bibliographic Details
Title: The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.
Authors: Muntoni, Francesco1,2 (AUTHOR), Byrne, Barry J.3 (AUTHOR), McMillan, Hugh J.4 (AUTHOR), Ryan, Monique M.5 (AUTHOR), Wong, Brenda L.6 (AUTHOR), Dukart, Juergen7,8 (AUTHOR), Bansal, Amita9 (AUTHOR), Cosson, Valerie9 (AUTHOR), Dreghici, Roxana9,10 (AUTHOR), Guridi, Maitea9 (AUTHOR), Rabbia, Michael11 (AUTHOR), Staunton, Hannah12 (AUTHOR), Tirucherai, Giridhar S.13 (AUTHOR), Yen, Karl11,14 (AUTHOR), Yuan, Xiling13 (AUTHOR), Wagner, Kathryn R.9,15 (AUTHOR) kathrynraewagner@gmail.com, the Taldefgrobep Alfa Study Group (AUTHOR), Carvajal, Irvith (AUTHOR), Chimalakonda, Anjaneya (AUTHOR), Gokemeijer, Jochem (AUTHOR)
Source: Neurology & Therapy. Feb2024, Vol. 13 Issue 1, p183-219. 37p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938253
DOI:10.1007/s40120-023-00570-w